Molecular studies of rheumatoid factor using pseudobioaffinity membrane chromatography

Journal of Molecular Recognition

Volumn 22, Issue 2, 2009, Pages 146-153

  Kamalanathan, A S ^a   Vijayalakshmi, M A ^a,b  

^a VIT UNIVERSITY   (India)

^b UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

Author keywords

Catalytic antibody; L His PEVA; Peptide hydrolysis; Rheumatoid arthritis; Rheumatoid factor; RNA and DNA hydrolysis

Indexed keywords

ANTI IGG; ANTI-IGG; ANTIIDIOTYPIC ANTIBODY; AUTOANTIBODY; DNA; HISTIDINE; IMMUNOGLOBULIN G; RHEUMATOID FACTOR; RIBONUCLEASE; RNA;

AFFINITY CHROMATOGRAPHY; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CHEMISTRY; HUMAN; HYDROLYSIS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MEMBRANE; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; RHEUMATOID ARTHRITIS; WESTERN BLOTTING;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIGEN-ANTIBODY COMPLEX; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BLOTTING, WESTERN; CHROMATOGRAPHY, AFFINITY; DNA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HISTIDINE; HUMANS; HYDROLYSIS; IMMUNOGLOBULIN G; MEMBRANES; RHEUMATOID FACTOR; RIBONUCLEASES; RNA;

EID: 63449090705     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.921     Document Type: Article

References (30)

1. Blank A, Dekker CA, 1981, Ribonucleases of human serum, urine, cerebrospinal fluid, and leukocytes. Activity staining following electrophoresis in sodium dodecyl sulfate-polyacrylamide gels. Biochemistry 20:2261-2267.
2. Buchner J, Renner M, Lilie H, Hinz HJ, Jaenicke R, Kiefhabel T, Rudolph R. 1991. Alternatively folded states of an immunoglobulin. Biochemistry 30: 6922-6929.
3. Bueno SMA, Haupt K, Vijayalakshmi MA. 1995. Separation of immunoglobulin G from human serum by pseudobioaffinity chromatography using immobilized L-histidine in hollow fiber membranes. J. Chromatogr. B: Biomed. Appl. 667: 57-67.
4. Bueno SMA, Legallais C, Haupt K, Vijayalakshmi MA. 1996. Experimental kinetic aspects of hollow fiber membrane based pseudoaffinity filtration: process for IgG separation from human plasma. J. Membr.Sci. 117:45-56.
5. Cohen PL, Cheek RL, Halder JA, Yount WJ, Eisenberg RA. 1987. The subclass distribution of human IgG rheumatoid factor. J. Immunol. 139: 1466-1471.
6. Darnige L, Legallais C, Arvieux J, Pitiot O, Vijayalakshmi MA. 1999. Functionalized hollow fiber membrane cartridge for adsorption of anticofactor/antiphospholipid antibodies: a potential tool for treatment. Artif. Organs 23: 834-839.
7. Edwards JCW, Cambridge G, 1998. Rheumatoid arthritis: The predictable effect of small immune complexes in which antibody is also antigen. Br. J. Rheumatol. 37: 126-130.
8. EI-Kak A, Vijayalakshmi MA. 1992. Separation and purification of IgGI and IgG2from IgG-Cohn-ll fraction of human plasma by pseudobioaffinity chromatography on histidyl-AH-sepharose. Bioseparation 3: 47-53.
9. Haupt K, Bueno SMA, Vijayalakshmi MA, 1995. Interaction of human immunoglobulin G with L-histidine immobilized onto poly (ethylene vinyl alcohol) hollow-fiber membranes. J. Chromatogr. B: Biomed. Appl. 674: 13-21.
10. Kalaga R, Li L, O'Dell JR, Paul S. 1995. Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis.J Immunol. 155: 2695-2702.
11. Marcelletti JF, Nakamura RM. 2003. Assessment of serological markers associated with rheumatoid arthritis: Diagnostic autoantibodies and conventional disease activity markers, Clin. Appl. Immunol. Rev. 4: 109-123.
12. Matsumoto A, Shikata K, Takeuchi F, Kojima N, Mizuochi T. 2000. Kinetic analysis of Interaction of different types of rheumatoid factors with immobilized IgG using surface plasma resonance. J. Biochem. 128: 621-628.
13. Matsuura K, Ikoma S, Sugiyama M, Funauchi M, Sinohara H. 2000. Amidase and peptidase activities of polyclonal immunoglobulin G present in the sera of patients with rheumatoid arthritis. Appl. Biochem. Biotechnol. 83: 107-113.
14. Nedonchelle E, Pitiot O, Vijayalakshmi MA. 2000. A preliminary study for isolation of catalytic antibodies by histidine ligand affinity chromatography as an alternative to conventional protein A/G methods. Appl. Biochem. Biotechnol. 83: 287-294.
15. Nevinsky GA, Kanyshkova TG, Buneva VN. 2000. Natural catalytic antibodies (abzymes) in normalcy and pathology. Biochemistry (Moscow) 65: 1245-1255.
16. Nevinsky GA, Buneva VN. 2002. Human catalytic RNA- and DNA-hydrolyzing antibodies. J. Immunol. Methods 269: 235-249.
17. Pitiot O. 2000. Utilization of pseudobioaffinity ligands for biomedical application. PhD Thesis, Université de Technologie de Compiegne, France.
18. Paul S, Volle DJ, Beach CM, Johnson RR, Powell MJ, Massey RJ. 1989. Catalytic hydrolysis of vasoactive intestinal peptides by human autoantibody. Science 244: 1158-1161.
19. Pope RM, Teller DC, Miannik M. 1974. The molecular basis of self association of antibodies to IgG (rheumatoid factors) in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 71: 517-521.
20. Sarath G, De La Motte RS, Wagner FW. 1989. Protease Assay Methods. Proteolytic Enzymes: A Practical Approach, Beyroun RJ, Bond JS (eds.), IRL Press: Oxford, UK; 25-55.
21. Shakib F, Stanworth DR. 1976. IgG subclass composition of rheumatoid arthritis sera and joint fluids. Ann. Rheum, Dis. 35: 263-266.
22. Shakib F, Stanworth DR. 1978. Antigammaglobulin(rheumatoid factor) activity of human IgG subclasses. Ann. Rheum. Dis. 37: 12-17.
23. Shuster AM, Gololobov GV, Kvashuk OK, Bogomolova AE, Smirnov IV, Gabibov AG. 1992. DNA hydrolyzing autoantibodies. Science 256: 665-667.
24. Soltys AJ, Axford JS, Sulton BJ. 1997. Rheumatoid factors: where are we now? Ann. Rheum. Dis. 56: 285-286.
25. Steiner G, Smolen J. 2002. Antibodies in rheumatoid arthritis and their clinical significance. Arthritis Res. 4: S1-S5.
26. van Boekel MAM, Vossernaor ER, van den Hoogen FH, van Venrooij WJ. 2001. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res. 4: 87-93,
27. Vlassov A, Florentz C, Helm M, Naumov V, Buneva V, Nevinsky G, Giegé R. 1998. Characterization and selectivity of catalytic antibodies from human serum with RNase activity. Nucleic Acids Res. 26: 5243-5250.
28. Vijayalakshmi MA. 1989. Pseudobiospecific ligands affinity chromatography. Trends Biotechnol. 7: 71-76.
29. Vijayalakshmi MA. 1998. Antibody purification methods. Appl. Biochem. Biotechnol. 75: 93-106.
30. Zack DJ, Stempniak M, Wong AL, Weisbart RH. 1995. Localization of an Fc-binding reactivity to the constant region of human IgG4. J. Immunol. 155: 5057-5063.